Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 3, 2013, Pages 1105-1114

  Harasymczuk, Malgorzata ^a,c   Gooding, William ^a   Kruk Zagajewska, Aleksandra ^c   Wojtowicz, Jerzy ^c   Dworacki, Grzegorz ^c   Tomczak, Hanna ^c   Szyfter, Witold ^c   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Endophytic growth; Exophytic growth; Head and neck squamous cell carcinoma (HNSCC); Immunohistochemistry; Recurrence free survival (RFS)

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CYTOKINE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE CLUSTER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REGULATORY T LYMPHOCYTE; STROMA CELL;

AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84878374663     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2117-1     Document Type: Article

References (33)

1. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890-1900
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
3. Brockstein BE (2011) Management of recurrent head and neck cancer: recent progress and future directions. Drugs 71:1551-1559
4. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB (2006) Head and neck cancer: past, present and future. Exp Rev Anticancer Ther 6:1111-1118
5. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B (1973) Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 12:1-8
6. Yilmaz T, Hosal AS, Gedikoglu G, Kaya S (1999) Prognostic significance of histopathological parameters in cancer of the larynx. Eur Arch Otorhinolaryngol 256:139-144
7. Sotiriou C, Lothaire P, Dequanter D, Cardoso F, Awada A (2004) Molecular profiling of head and neck tumors. Curr Opin Oncol 16:211-214
8. Patel SG, Shah JP (2005) TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242-258
9. Spiro RH, Guillamondegui O Jr, Paulino AF, Huvos AG (1999) Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21:408-413
10. Hussein MR, Cullen K (2001) Molecular biomarkers in HNSCC: prognostic and therapeutic implications. Expert Rev Anticancer Ther 1:116-124
11. Yilmaz T, Gedikoglu G, Gursel B (2003) The relationship between tumor thickness and clinical and histopathologic parameters in cancer of the larynx. Otolaryngol Head Neck Surg 129:192-198
12. Boheim K, Boheim C, Rauchegger H (1981) Induction chemotherapy with cis-platinum in head and neck tumors. First clinical and histopathologic findings. Arch Otorhinolaryngol 233:31-40
13. Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH (2008) Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 134:1196-1204
14. Shintani S, Matsuura H, Hasegawa Y, Nakayama B, Fujimoto Y (1997) The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology 54:463-467
15. Kurokawa H, Yamashita Y, Murata T, Yoshikawa T, Tokudome S, Miura K, Kajiyama M (1998) Histological grading of malignancy correlates with regional lymph node metastasis and survival of patients with oral squamous cell carcinoma. Fukuoka Igaku Zasshi 89:225-231
16. Nigauri T, Kamata SE, Kawabata K, Nakamizo M, Hoki K, Mitani H, Nagahashi T, Yokoshima K, Yoshimoto S (1996) Prognostic factors of lateral wall oropharyngeal squamous cell carcinoma - retrospective study of 79 patients. Nihon Jibiinkoka Gakkai Kaiho 99:1190-1199
17. Whiteside TL (1993) Tumor-infiltrating lymphocytes in human malignancies. In: Medical Intelligence Unit, R.G. Landes Co., Austin, TX
18. Yu P, Fu YX (2006) Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 86:231-245
19. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964
20. Distel LV, Fickenscher R, Dietel K, Hung A, Iro H, Zenk J, Nkenke E, Buttner M, Niedobitek G, Grabenbauer GG (2009) Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol 45:e167-e174
21. Whiteside TL (2001) Immunobiology and immunotherapy of head and neck cancer. Curr Oncol Rep 3:46-55
22. Whiteside TL (2002) Tumor-induced death of immune cells: its mechanisms and consequences. Sem Cancer Biol 12:43-50
23. + T cells in the peripheral circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13:6301-6311
24. Ferrone S, Whiteside TL (2007) Tumor microenvironment and immune escape. Surg Oncol Clin N Am 16:755-774
25. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949
26. + T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186-192
27. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL (2001) The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91:2136-2147
28. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL (2009) Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69:3105-3113
29. Amin MB, Gomez JA, Young RH (1997) Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 21:1057-1068
30. Stoliarov VI, Kolosov AE, Dovgaliuk AZ (1990) The prognostic significance of the anatomical forms of esophageal cancer. Vopr Onkol 36:1067-1071
31. Steinhart H, Kleinsasser O (1993) Growth and spread of squamous cell carcinoma of the floor of the mouth. Eur Arch Otorhinolaryngol 250:358-361
32. + B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 9:292-302
33. Whiteside TL, Parmiani G (1994) Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 39:15-21